GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » FCF Margin %

BRKR (Bruker) FCF Margin % : 0.67% (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bruker FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bruker's Free Cash Flow for the three months ended in Sep. 2024 was $6 Mil. Bruker's Revenue for the three months ended in Sep. 2024 was $864 Mil. Therefore, Bruker's FCF Margin % for the quarter that ended in Sep. 2024 was 0.67%.

As of today, Bruker's current FCF Yield % is 1.79%.

The historical rank and industry rank for Bruker's FCF Margin % or its related term are showing as below:

BRKR' s FCF Margin % Range Over the Past 10 Years
Min: 4.45   Med: 7.32   Max: 12.01
Current: 4.83


During the past 13 years, the highest FCF Margin % of Bruker was 12.01%. The lowest was 4.45%. And the median was 7.32%.

BRKR's FCF Margin % is ranked better than
68% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -4.43 vs BRKR: 4.83


Bruker FCF Margin % Historical Data

The historical data trend for Bruker's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker FCF Margin % Chart

Bruker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.77 11.82 7.87 5.74 8.20

Bruker Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.32 20.36 0.06 -2.93 0.67

Competitive Comparison of Bruker's FCF Margin %

For the Medical Devices subindustry, Bruker's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bruker's FCF Margin % falls into.



Bruker FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bruker's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=243.2/2964.5
=8.20 %

Bruker's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=5.8/864.4
=0.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bruker FCF Margin % Related Terms

Thank you for viewing the detailed overview of Bruker's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bruker Business Description

Traded in Other Exchanges
Address
40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Executives
Richard A Packer director 9 KENDALL DRIVE, WESTBOROUGH MA 01581
Frank H Laukien director, 10 percent owner, officer: CEO, President C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821
Bob Rosenthal director 20 NEWBURY ST, BOSTON MA 02116
Hermann Fritz Requardt director C/O BRUKER CORP., 40 MANNING ROAD, BILLERICA MA 01821
Burkhard Prause officer: Pres. & CEO, Bruker EST BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Marc A Kastner director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Cynthia M Friend director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Philip Ma director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Mark Munch officer: Pres. Bruker Nano Inc. BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Juergen Srega officer: Group President Bruker CALID BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Bonnie H Anderson director 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Martin Gilles Gerard Jean director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Falko Busse officer: President, BioSpin Group 40 MANNING ROAD, BILLERICA MA 01821
Gerald N Herman officer: Vice President, Corp Contr. 55 EXECUTIVE DRIVE, HUDSON NH 03051
Ingen Chris Van director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306